22.12.2012 Views

3. FOOD ChEMISTRy & bIOTEChNOLOGy 3.1. Lectures

3. FOOD ChEMISTRy & bIOTEChNOLOGy 3.1. Lectures

3. FOOD ChEMISTRy & bIOTEChNOLOGy 3.1. Lectures

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chem. Listy, 102, s265–s1311 (2008) Food Chemistry & Biotechnology<br />

P94 DISTRIbuTION OF DIAZINON IN<br />

VARIOuS TISSuES AND ITS EFFECT ON<br />

SERuM ChOLINESTERASE AFTER AN<br />

INTRAPERITONEAL ADMINISTRATION<br />

BRAnISLAV ŠIŠKA, JOZEF GOLIAn, ROBERT<br />

TOMAn and AnDREA KRAJČíROVá<br />

Department of Food Hygiene and Safety, Faculty of Biotechnology<br />

and Food Sciences, Slovak Agricultural University in<br />

Nitra,Trieda A. Hlinku 2, 949 76 Nitra,<br />

branislav.siska@gmail.com<br />

Introduction<br />

Diazinon (O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl<br />

phosphorothioate) belongs to the group of organophosphate<br />

insecticides used to control cockroaches, fleas and<br />

ants. It is also used to control a wide variety of sucking and<br />

leaf eating insects and it has also veterinary use 1 .<br />

Diazinon has toxic effect on nervous system. This effect<br />

is achieved through the inhibition of acetylcholinesterase<br />

2 . This enzyme has a key role in process for controlling of<br />

nervous signal transfer. Lack of acetylcholinesterase causes<br />

accumulation of acetylcholine. Accumulation of this neurotransmitter<br />

on the connections between nerves and muscles<br />

causes uncontrolled muscular contraction and algospasmus,<br />

between nerves and glands causes continual secretion of<br />

these glands, while acetylcholine cumulation between certain<br />

nerve cells in a brain causes sensory behavior disorders 3 .<br />

Diazinon is also able to cause oxidative stress of the<br />

organism through the forming of free radicals that are formed<br />

during the increased overextension of the organism by pesticides<br />

4,5 .<br />

LD 50 (letal dose for 50 % of tested animals) for diazinon<br />

is very different depending up to the species of used<br />

laboratory animal. For rats, this value was established to be<br />

1250 mg kg –1 after peroral administration and for laboratory<br />

mice 80–135 mg kg –1 of diazinon after peroral administration.<br />

ADI value (acceptable daily intake) was established on<br />

0.002 mg kg –1 of diazinon per day 3,6 . Typical symptoms of<br />

poisoning are weakness, headaches, tightness in the chest,<br />

blurred vision, nonreactive pinpoint pupils, salivation, sweating,<br />

nausea, vomiting, diarrhea, abdominal cramps, and slurred<br />

speech. Some researches pointed out that diazinon has<br />

also mutagenic effect, however current evidence is inconclusive<br />

3,7 . When it comes for a carcinogenic effect, diazinon is<br />

not considered to be a carcinogenic compound 7 .<br />

Metabolism and excretion rates for diazinon are rapid.<br />

The half-life of diazinon in animals is about 12 hours. The<br />

product is passed out of the body through urine and in the<br />

feces. The metabolites account for about 70 % of the total<br />

amount excreted. Diazinon does not belong to the group of<br />

chemicals that is characteristic with the long-lasting cumulation<br />

in human or animal tissues. However, in some cases<br />

could be diazinon detected in the samples of fat tisse, because<br />

this tissue has certain ability to cumulate organophosphate<br />

insecticides for relatively short period of time.Cattle exposed<br />

s789<br />

to diazinon may store the compound in their fat over the short<br />

term 8 .<br />

In this assay, we studied the effect of diazinon intraperitoneal<br />

administration on rat serum cholinesterase catalytic<br />

activity and the distribution of diazinon in various tissues of<br />

organs of experimental animals.<br />

Experimental<br />

Laboratory rats in the age of 135 days were randomly<br />

divided into 2 groups. Each group consisted of 10 males.<br />

Animals in the first group were administrated with diazinon<br />

(Sigma, USA) 20 mg kg –1 b.w. intraperitoneally in physiological<br />

solution. The second group served as a control group<br />

and was administrated only with the physiological solution.<br />

24 hours after the administration of tested substance, animals<br />

were sacrificed, blood samples were taken from hearts and<br />

samples of livers, kidneys, muscles and fat tissue were taken<br />

during the autopsy.<br />

Catalytic activity of cholinesterase was determined with<br />

using of Bio-La-Test ® . The amount of diazinon in tissues<br />

was determined with using of gas chromatography with mass<br />

spectrometry.<br />

Basic statistical characteristics – arithmetic mean, standard<br />

deviation and variation coefficient were calculated for<br />

cholinesterase catalytic activity and for amount of diazinon<br />

in each group. Obtained data were then processed in order<br />

to determinate statistical significance of the results. The<br />

Student’s t-test was finally used for establishment of statistical<br />

significance.<br />

Results<br />

no deaths were observed in any of groups of experimental<br />

animals. However, animals from diazinon treted group<br />

approximately 12 hours after the administration of diazinon<br />

showed symptoms connected with depression of cholinesterase<br />

activity and did not react on external stimuli. Results of<br />

the determination of cholinesterase activity are presented in<br />

Table I.<br />

Table I<br />

Cholinesterase activity (μkat dm –3 ) in different groups<br />

Cholinesterase activity Variation<br />

Group of animals activity coefficient<br />

(X ± SD) [%]<br />

Dizinon group 1.81 ± 0.79 * 44<br />

Control group <strong>3.</strong>69 ± 0.51 14<br />

X – arithmetic mean, SD – standard deviation,<br />

* p-value < 0.05<br />

Changes of cholinesterase catalytic activity were observed<br />

in diazinon treated animals. We observed significant decrease<br />

of cholinesterase catalytic activity from <strong>3.</strong>69 µkat dm –3 in<br />

control group to 1.81 µkat dm –3 in experimental group. Muscular<br />

weakness, confuse and lethargy were typical symptoms<br />

that were observed on experimental animals in our assay.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!